Two-thirds of patients attending a urology clinic for the management of urolithiasis failed to meet physical activity guidelines. In addition, patients with recent symptomatic urolithiasis were significantly more likely to be current smokers than those without recent symptomatic urolithiasis, according to a recent study.
"With better education and research, our stone patients can decrease their disease risk and improve their overall health sooner rather than later," writes Stephen Y. Nakada, MD.
In this interview, Dr. Wong describes difficult stones, discusses the skills and training required to treat them, and outlines the role of different treatment modalities.
Despite ureteroscopy's high success results, there is still a role for shock wave lithotripsy in treating stones, urologists say.
Check out the latest new products. From Single-use ureteroscope addresses shortcomings of reusable scopes, to an App that helps IC, chronic prostatitis patients choose the right foods and much more.
The authors sought to identify factors associated with 30-day emergency department visits and readmission following URSLL.
Other pipeline products discussed in this article include an immunotherapy for metastatic bladder cancer, a treatment for lower urinary tract symptoms of BPH, and an investigational clear cell renal cell carcinoma treatment.
Learn more about these products as well as a powered exam table and an app that measures, monitors, and helps improve fertility in men.
Economic analyses of surgeries to treat SUI also do not routinely capture long-term complications, researchers say.
Study examines real-world effectiveness of percutaneous tibial nerve stimulation for treating overactive bladder.
When it comes to urinary stone disease, it appears that prescribers know what they’re doing. According to a study presented at the World Congress of Endourology and SWL in London, non-adherence to kidney stone medications led to a significant increase in adverse health outcomes.
In this interview, Karl-Erik Andersson, MD, PhD, discusses current treatments for common voiding dysfunctions and future directions, including central nervous system agents and combination therapies.
Findings from preclinical studies evaluating the performance of an investigational single-use digital flexible ureteroscope (Lithovue, Boston Scientific) support it as a viable alternative to current non-disposable flexible digital and fiberoptic ureteroscopes, said Brian H. Eisner, MD, at the World Congress of Endourology and SWL in London.
Other pipeline products discussed in this article include agents for urinary catheter blockage, prostate cancer, bladder cancer, and overactive bladder.
The authors evaluated cumulative incidence of re-operation after various surgical procedures for urinary incontinence within 5 years.
A recent systematic review found that the total incidence of serious complications and/or sling failure with respect to incontinence was 15.3%.
A novel artificial urinary sphincter is safe and effective in men with stress urinary incontinence, according to data from a small study presented at the International Continence Society annual meeting in Montreal.
The Adjustable Transobturator Male System addresses one of the challenges with slings.
Novel ultrasound-based techniques for propelling and breaking kidney stones could soon join ESWL and URS in the urologist’s treatment armamentarium. In this interview, Michael Bailey, PhD, discusses how these technologies work, what they’re capable of, and where they are in development.
A robot-assisted abdominal approach to pelvic organ prolapse repair has a favorable safety profile and is associated with durable anatomic outcomes, findings of a retrospective chart review indicate.
Other products highlighted in this slideshow include a trial system for incontinence therapy, a compact catheter, a wearable digital technology solution for continence care assessment and management, and laser fiber and sheath system.
A prostate cancer vaccine and an infertility diagnostic tool are among the other pipeline products discussed in this round-up.
OnabotulinumtoxinA (Botox) appears to offer long-term benefits in patients with neurogenic detrusor overactivity, recent study results indicate.
Symptomatic urinary tract infection is unlikely after office-based cystoscopy, although recent antibiotic exposure or hospitalization raise infection risk, according to a recent study.
A recent study evaluated electrical stimulation of the afferent nerves in the foot as a way of decreasing symptoms of overactive bladder.
